IMC-1121B
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for IMC-1121B, covering 2013-08-19 to 2014-12-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]